RiverFront Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

RiverFront Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.47M	Buy	4,936 +105	+2%	+$50.4K	0.03%	158
2026 Q1	$2.37M	Buy	4,831 +138	+3%	+$74.9K	0.04%	132
2025 Q4	$2.72M	Sell	4,693 -77	-2%	-$43.5K	0.04%	109
2025 Q3	$2.31M	Buy	4,770 +199	+4%	+$92.6K	0.04%	113
2025 Q2	$1.85M	Buy	4,571 +113	+3%	+$47.2K	0.04%	111
2025 Q1	$2.22M	Buy	4,458 +3,974	+821%	+$2.15M	0.05%	98
2024 Q4	$252K	Buy	484 +105	+28%	+$57.7K	0.01%	217
2024 Q3	$234K	Buy	+379	New	+$224K	0.01%	194

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RiverFront Investment Group's TMO Position: Q2 2026 in Review

RiverFront Investment Group increased its Thermo Fisher Scientific (TMO) stake by 2.2% in Q2 2026, buying an estimated $50.4K and bringing the position to 4,936 shares worth $2.47M. The position accounts for 0.03% of the portfolio, ranked #158.

RiverFront Investment Group first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.72M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

RiverFront Investment Group held 4,936 shares of Thermo Fisher Scientific worth $2.47M as of Q2 2026.
RiverFront Investment Group bought 105 Thermo Fisher Scientific shares in Q2 2026, an estimated $50.4K.
Thermo Fisher Scientific made up 0.03% of RiverFront Investment Group's portfolio in Q2 2026, its #158 holding.
RiverFront Investment Group first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
RiverFront Investment Group's Thermo Fisher Scientific position peaked at $2.72M in Q4 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.